Calcium Acetate NDC 62135-191

NDC codes

FDA NDC Directory

Product NDC (as listed)62135-191Labeler and product segments. Claims need a package NDC.

Product NDC at billing width62135-0191Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
62135-191-22	62135019122	200 CAPSULE in 1 BOTTLE (62135-191-22)Marketed from Jun 29, 2018
62135-191-30	62135019130	30 CAPSULE in 1 BOTTLE (62135-191-30)Marketed from Jun 29, 2018
62135-191-73	62135019173	750 CAPSULE in 1 BOTTLE (62135-191-73)Marketed from Jun 29, 2018

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Calcium Acetate
Generic name (nonproprietary): calcium acetate
Active ingredients: Calcium acetate — 667 mg/1
Dosage form: Capsule
Route: Oral
Labeler: Chartwell RX, LLC.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 091312
Marketing start: Jun 29, 2018
Listing expires: Dec 31, 2026
Other FDA classes: Calcium (Chemical structure)Divalent (Chemical structure)Increased Coagulation Factor Activity (Physiologic effect)Phosphate Chelating Activity (Mechanism)
Identifiers: Product ID 62135-191_06d3e4e6-38bb-e690-e063-6294a90af4d1SPL ID 06d3e4e6-38bb-e690-e063-6294a90af4d1SPL set ID 781c3f1f-b622-418b-8c0e-3407e9b90656RxCUI 359296UNII Y882YXF34X
Pharmacologic class: Blood Coagulation Factor; Phosphate Binder

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N462135019122 followed by a unit qualifier and the quantity

Package 62135-0191-22. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 3, 2023.

Indications (excerpt from the label)

Calcium acetate is a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (ESRD). Calcium acetate is a phosphate binder indicated for the reduction of serum phosphorus in patients with end stage renal disease. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)